The Importance of Early Diagnosis and Real-World Evidence to Drive Better Patient Outcomes
Of the 500,000 people across Europe who live with a rare neurological disease, 60% remain undiagnosed.1 A recent roundtable event, Rare Neurological Diseases in the EU, explored how early diagnosis and real-world evidence can help.
